Literature DB >> 30685807

Activity of temocillin and comparators against clinical isolates of Vibrio cholerae from Iran.

Mohammad Rahbar1, Rogieh Saboorian1, Sebastien Van de Velde2, Marjan Rahnamaye Farzami3, Masoud Mardani4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30685807     DOI： 10.1007/s10096-019-03483-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  Getting serious about cholera.

Authors:  David A Sack; R Bradley Sack; Claire-Lise Chaignat
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

Review 2.  Temocillin revived.

Authors:  David M Livermore; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2008-12-18       Impact factor: 5.790

3.  Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.

Authors:  Raf De Jongh; Ria Hens; Violetta Basma; Johan W Mouton; Paul M Tulkens; Stéphane Carryn
Journal:  J Antimicrob Chemother       Date:  2007-12-10       Impact factor: 5.790

4.  Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.

Authors:  Liliana Candida Dengo-Baloi; Cynthia Amino Semá-Baltazar; Lena Vania Manhique; Jucunu Elias Chitio; Dorteia Luísa Inguane; José Paulo Langa
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

5.  Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters.

Authors:  Nadja Bier; Keike Schwartz; Beatriz Guerra; Eckhard Strauch
Journal:  Front Microbiol       Date:  2015-10-28       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.